Funding search · Alzheimer'S Disease Research Foundation · grants

Alzheimer'S Disease Research Foundation: all 448 grants

Largest first · $100.1M across 2022–2025 · back to the overview

$2.0M
Massachusetts General Hospital · Boston, MA · 2025
The curealz alzheimer's genome project
$2.0M
Massachusetts General Hospital · Boston, MA · 2024
The curealz alzheimer's genome project
$2.0M
Massachusetts General Hospital · Boston, MA · 2023
The curealz alzheimer's genome project
$2.0M
Massachusetts General Hospital · Charlestown, MA · 2022
Thecurealzalzheimers genome project
$575,000
Brigham and Women'S Hospital · Boston, MA · 2025
Apoe4 accelerates cd8 exhaustion via glucocorticoid signaling in alzheimer's female carriers
$575,000
Brigham and Women'S Hospital · Boston, MA · 2024
Apoe: apoe4 accelerates cd8 exhaustion via glucocorticoid signaling in alzheimer's female carriers
$431,250
Brigham and Women'S Hospital · Boston, MA · 2025
A new model of microglia genetic perturbation in vivo to screen all risk factors associated with alzheimer's disease
$431,250
Brigham and Women'S Hospital · Boston, MA · 2023
A new model of microglia genetic perturbation in vivo to screen all risk factors associated with alzheimer's disease
$402,500
University of Michigan · Ann Arbor, MI · 2025
Non-invasive modulation of microglia gene expression using peripherally administered antibody conjugates
$402,500
Weill Medical College of Cornell University · New York, NY · 2025
Sex-biased tlr7 signaling in demyelination and its inhibition by small molecules
$402,500
Weill Medical College of Cornell University · New York, NY · 2024
Sex-biased tlr7 signaling in demyelination and its inhibition by small molecules
$402,492
University of California Irvine · Irvine, CA · 2025
Proteomic signatures of cerebrovascular neuropathology in down syndrome with alzheimer disease
$398,521
University of Michigan · Ann Arbor, MI · 2025
Utilizing heterogeneous mouse models to discover mechanisms underlying caloric restriction (cr) on cognitive outcomes
$345,000
Washington University in St Louis · St Louis, MO · 2025
Apoe consortium: investigating potential cell autonomous neuroprotection of apoe protective variants
$345,000
Washington University in St Louis · St Louis, MO · 2025
Bee: meningeal mast cell control of csf dynamics in homeostasis and alzheimer's disease
$345,000
Washington University in St Louis · St Louis, MO · 2025
Bac: identifying age-related proteomic changes that predict future onset of amyloid-beta aggregation in alzheimer's disease
$345,000
Northwestern University · Chicago, IL · 2024
Mbc: interaction of the microbiome with astrocytes and amyloid pathology
$345,000
Washington University in St Louis · St Louis, MO · 2024
Apoe: investigating potential cell autonomous neuroprotection of apoe protective variants
$345,000
Washington University in St Louis · St Louis, MO · 2024
Bee: meningeal mast cell control of csf dynamics in homeostasis and alzheimer's disease
$345,000
Massachusetts General Hospital · Boston, MA · 2023
Neuroprotective effects of the exercise hormone irisin in alzheimer's disease
$345,000
Northwestern University · Chicago, IL · 2023
Mbc: interaction of the microbiome with astrocytes and amyloid pathology
$345,000
Washington University · St Louis, MO · 2023
Apoe consortium: role of apoe isoforms in immune responses in a model of tauopathy
$345,000
Washington University · St Louis, MO · 2023
Bee: crosstalk of cns barriers and clearance routes in homeostasis and alzheimer's disease
$345,000
Washington University · St Louis, MO · 2022
Bee: crosstalk of cns barriers and clearance routes in homeostasis and alzheimers disease
$345,000
Washington University · St Louis, MO · 2022
Apoe consortium: role of apoe isoforms in immune responses in a model of tauopathy
$344,528
Boston Children'S Hospital · Boston, MA · 2025
Nic: effects of peripheral inflammation on myeloid cell function in alzheimer's disease
$344,085
Boston Children'S Hospital · Boston, MA · 2023
Nic: effects of peripheral inflammation on myeloid cell function in alzheimer's disease
$327,501
The McLean Hospital Corporation · Belmont, MA · 2025
Expanding postmortem brain resources for alzheimer's disease in diverse populations
$320,033
Duke University School of Medicine · Durham, NC · 2025
Utility of blood based markers for predicting aria and its course in mci and ad subjects undergoing routine clinical treatment with amyloid-directed antibodies
$307,500
Whitehead · Cambridge, MA · 2022
Circuits: impact of epigenetic and cellular variants on alzheimers disease pathology
$301,069
University of Southern California · Los Angeles, CA · 2023
Air pollution and ad risk interact with premature aging of neural stem cells and apoe alleles
$300,000
Massachusetts General Hospital · Boston, MA · 2025
Understanding human brain resilience to alzheimer's pathology
$300,000
Massachusetts General Hospital · Boston, MA · 2024
Understanding human brain resilience to alzheimer's pathology
$300,000
Massachusetts Institute of Technology · Cambridge, MA · 2024
Dissecting microglial state dynamics in alzheimer's disease
$300,000
Massachusetts General Hospital · Boston, MA · 2023
Understanding human brain resilience to alzheimer's pathology
$300,000
Massachusetts Institute of Technology · Cambridge, MA · 2023
Circuits: dissecting microglial state dynamics in alzheimer's disease
$300,000
Boston Children'S Hospital · Boston, MA · 2022
Nic: understanding the consequences of non-coding ad risk alleles on microglia function
$287,673
National Institute of Neurological Disorders & Stroke · Bethesda, MD · 2025
Bee: high-resolution mri of the brain borders
$287,500
Massachusetts General Hospital · Boston, MA · 2025
Bee: human 3d neuro-vascular interaction and meningeal lymphatics models with application to alzheimer's disease
$287,500
New York University School of Medicine · New York, NY · 2025
Nic: astrocyte inflammatory contributions to ad
$287,500
Regents of the University of California San Diego · La Jolla, CA · 2025
Nic: mechanisms mediating microglia sensing of peripheral inflammation
$287,500
Regents of the University of California San Diego · La Jolla, CA · 2025
Bee: how does vascular fatty acid metabolism regulate the pathophysiology of alzheimer's disease?
$287,500
Stanford University · Redwood City, CA · 2025
Bac: choroid plexus aging and alzheimer's disease
$287,500
University of Rochester · Rochester, NY · 2025
Bee: does slym failure compromise glymphatic clearance in alzheimer's disease?
$287,500
Washington University in St Louis · St Louis, MO · 2025
Bac: brain region and cell-type specific aging from accelerated to resilient trajectories
$287,500
Massachusetts General Hospital · Boston, MA · 2024
Bee: human 3d neuro-vascular interaction and meningeal lymphatics models with application to alzheimer's disease
$287,500
Massachusetts General Hospital · Boston, MA · 2024
Alzheimer's disease tau consortium: toxic consequences of early tau seeding
$287,500
Massachusetts General Hospital · Boston, MA · 2024
Mbc: microbial profiling of human brain and gut microbiomes in alzheimer's disease.
$287,500
National Institute of Neurological Disorders & Stroke · Bethesda, MD · 2024
Bee: high-resolution mri of the brain borders
$287,500
New York University School of Medicine · New York, NY · 2024
Neuroimmune consortium: astrocyte inflammatory contributions to alzheimer's disease
$287,500
University of California San Diego · La Jolla, CA · 2024
Bee: how does vascular fatty acid metabolism regulate the pathophysiology of alzheimer's disease?
$287,500
University of Rochester · Rochester, NY · 2024
Bee: does slym failure compromise glymphatic clearance in alzheimer's disease?
$287,500
Washington University in St Louis · St Louis, MO · 2024
Mbc: the role of gut microbial metabolism in tau-mediated neurodegeneration
$287,500
Boston University · Boston, MA · 2023
Apoe consortium: modulation of selective neuronal vulnerability in alzheimer's disease by apoe
$287,500
Brigham and Women'S Hospital · Boston, MA · 2023
Apoe consortium: apoe4-mediated dysfunction of cd8 t cell-microglia crosstalk in alzheimer's disease
$287,500
Brigham and Women'S Hospital · Boston, MA · 2023
Mbc: harnessing diet-microbe interactions to prevent alzheimer's disease pathogenesis
$287,500
Massachusetts General Hospital · Boston, MA · 2023
Mbc: microbial profiling of human brain and gut microbiomes in alzheimer's disease
$287,500
University of California San Diego · La Jolla, CA · 2023
Bee: identifying the blood-brain barrier changes during alzheimer's disease
$287,500
University of California San Diego · La Jolla, CA · 2023
Nic: mechanisms mediating microglia sensing of peripheral inflammation
$287,500
Washington University · St Louis, MO · 2023
Mbc: the role of gut microbial metabolism in tau-mediated neurodegeneration
$287,500
Weill Cornell · New York, NY · 2023
Bee: biochemical and functional analysis of csf and lymph following changes in brain fluid dynamics
$287,500
Brigham and Women'S · Boston, MA · 2022
Apoe consortium: apoe4-mediated dysfunction of cd8 t cell-microglia crosstalk in alzheimers disease
$287,500
Massachusetts General Hospital · Charlestown, MA · 2022
Nic: biomarker tool development in caf neuroimmune consortium
$287,500
University of California San Diego · La Jolla, CA · 2022
Bee: identifying the blood-brain barrier changes during alzheimers disease
$287,500
Weill Cornell · New York, NY · 2022
Bee: biochemical and functional analysis of csf and lymph following changes in brain fluid dynamics
$287,499
Washington University in St Louis · St Louis, MO · 2025
Bac: establishing isogenic models of human neuron aging and pathways relevant for alzheimer's disease
$287,493
University of California Irvine · Irvine, CA · 2023
Nic: examining the impact of peripherally derived human macrophages in ad pathogenesis
$287,490
University of California Irvine · Irvine, CA · 2025
Nic: examining the impact of peripherally derived human macrophages in ad pathogenesis
$287,477
Massachusetts Institute of Technology · Cambridge, MA · 2025
Bac: investigating lipidomic perturbations in the csf with age and alzheimer's disease progression: toward mechanistic insights and accessible lipid biomarkers
$287,276
University of Texas Southwestern Medical Center · Dallas, TX · 2024
Alzheimer's disease tau consortium: strain replication in mouse and cell models
$287,169
Massachusetts General Hospital · Boston, MA · 2023
Adtc: how do soluble tau species replicate?
$287,000
University of Texas Southwestern Medical Center · Dallas, TX · 2023
Adtc: role of vcp/p97 in tau prion replication
$287,000
University of Texas Southwestern Medical Center · Dallas, TX · 2022
Adtc: the role of vcp/p97 in tau prion replication
$286,595
Massachusetts General Hospital · Charlestown, MA · 2022
Adtc: how do soluble tau species replicate?
$286,559
Northwestern University · Chicago, IL · 2024
Alzheimer's disease tau consortium: the role of ab - induced membrane damage in tau pathology
$286,466
University of California Davis · Davis, CA · 2025
Nic: impact of ad polygenic risk score on microglial response to peripheral inflammation
$286,448
Northwestern University · Chicago, IL · 2023
Adtc: the role of a-induced membrane damage in tau pathology
$286,357
Northwestern · Chicago, IL · 2022
Adtc: the role of a-induced membrane damage in tau pathology
$285,952
University of Pennsylvania · Philadelphia, PA · 2024
Apoe: cell autonomous roles of protective apoe variants in microglia responding to amyloid pathology
$285,851
University of California Davis · Davis, CA · 2024
Neuroimmune consortium: impact of ad polygenic risk score on microglial response to peripheral inflammation
$284,678
University of Pennsylvania · Philadelphia, PA · 2025
Apoe consortium: cell autonomous roles of protective apoe variants in microglia responding to amyloid pathology
$275,500
Brigham and Women'S Hospital · Boston, MA · 2024
Mbc: harnessing diet-microbe interactions to prevent alzheimer's disease pathogenesis
$271,375
University of Alabama at Birmingham · Birmingham, AL · 2025
Expanding deep south inclusion in the uab adrc neuropathology core brain bank
$268,750
Duke University School of Medicine · Durham, NC · 2024
Plasma proteins, sex and alzheimer's diease: proteomewide analyses of the uk biobank and framingham heart study
$264,500
Boston Children'S Hospital · Boston, MA · 2025
Bee: neuroinflammation at the choroid plexus in alzheimer's disease (supplement)
$258,750
Massachusetts General Hospital · Boston, MA · 2025
Alzheimer's disease tau consortium: toxic consequences of early tau seeding (cfsf supplement)
$258,750
Massachusetts General Hospital · Boston, MA · 2025
Exploring novel drug candidates for alzheimer's disease through integrative pathway analysis and validation in 3d cellular models (cfsf supplement)
$258,750
University of Virginia · Charlottesville, VA · 2025
The role of planar cell polarity proteins in tau oligomer-induced synapse degeneration (cfsf supplement)
$258,750
Weill Medical College of Cornell University · New York, NY · 2025
A three-dimensional tissue model linking tau tangles, ab and microglial cd33- isoform state to gene- and isoform-expression dysregulation (cfsf supplement)
$258,750
Washington University in St Louis · St Louis, MO · 2024
Dissecting alzheimer's disease phenotypes in directly reprogrammed patient-derived neurons
$258,750
Massachusetts General Hospital · Boston, MA · 2023
Functional changes to cerebrospinal fluid immune cells resulting from bacillus calmette-gurin (bcg) vaccination in older adults with and without alzheimer's disease
$258,615
Gladstone Institutes · San Francisco, CA · 2025
Decoding protein transport across the blood-brain barrier to enable new alzheimer's therapies (cfsf supplement)
$258,573
Gladstone Institutes · San Francisco, CA · 2025
Developing cell-type-specific enhancer-aav vectors to characterize and restore ab- and tau-dependent circuit and cognitive deficits in humanized alzheimer's mouse models (cfsf supplement)
$252,077
Washington University · St Louis, MO · 2022
Apoe: assessing the added diagnostic value of peripheral apoe protein levels in current blood-based biomarker assays for cns amyloidosis
$252,076
Massachusetts General Hospital · Boston, MA · 2025
Menopause and related midlife risk factors and their impact on pathology and cognition - the whimsyad study
$250,000
The University of Chicago · Chicago, IL · 2024
Microbiome consortium: temporal relationships between gut dysbiosis, brain ab metabolism and microglia cell activation following antibiotic treatment
$250,000
University of Chicago · Chicago, IL · 2023
Mbc: temporal relationships between gut dysbiosis, brain ab metabolism and microglia cell activation following antibiotic treatment
$250,000
University of Southern California · Los Angeles, CA · 2023
Cellular and molecular studies of apoe regulation of blood-brain barrier, synaptic and neuronal functions and protection strategies in mouse models with and without alzheimer's pahtology
$250,000
Weill Cornell · New York, NY · 2023
Development of human cgas inhibitors to treat alzheimer's disease
$250,000
Harvard Medical School · Boston, MA · 2022
Nic: assessing the links between the ms4a risk genes, microglia, and alzheimers disease